Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities Abound

JAMA Netw Open. 2021 Jul 1;4(7):e2114606. doi: 10.1001/jamanetworkopen.2021.14606.

Authors

Jennifer J Manly¹, Andrea Gilmore-Bykovskyi², Kacie D Deters³

Affiliations

¹ Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Irving Medical Center, New York, New York.
² School of Nursing, University of Wisconsin-Madison, Madison.
³ Department of Neuroscience, University of California San Diego, La Jolla.

PMID: 34228130
DOI: 10.1001/jamanetworkopen.2021.14606

No abstract available

Publication types

Comment

MeSH terms

Alzheimer Disease*
Humans
Minority Groups
Patient Selection